Simplify your artwork process, get closer to your customers and strengthen compliance.

Global Life Science technology company Perigord has just released GLAMS CMO, the latest product in its suite of dedicated Life Science Workflow Management Solutions.

GLAMS CMO is a purpose-built artwork process management system designed specifically for Contract Manufacturing Organisations (CMOs). GLAMS CMO demystifies and simplifies the artwork process, a highly regulated and compliance-driven function within the packaging supply chain. It provides a portal for CMO clients to view and approve artwork in real-time, strengthening client relationships, it provides a solid link between the CMO and their Pharma clients!

“We are enormously proud of our latest product and its ability to improve CMOs ability to manage their artwork processes, create a business advantage, gaining an edge in an increasingly competitive market,” said Perigord CEO, Alan Leamy.

With shortening lead times and two-thirds of pharmaceutical manufacturing now being outsourced, CMOs need to have in place a best in class automated management system that underscores their ability to meet the demands of this highly regulated industry. Validated by the world’s leading life science businesses the GLAMS platform creates a vital bridge between CMOs and large pharma delivering a real competitive advantage.

GLAMS CMO leverages the power of Perigord Data’s proprietary global labelling artwork management platform, the world’s only dedicated workflow management system specifically designed for the life science industry.

“Patient safety and process optimisation are at the core of everything we do. Our clients trust us to deliver this into the supply chain. The success of GLAMS allows us to walk into any pharmaceutical company in the world and know that we can add value from the very first meeting,” explained Mr Leamy.

Embracing digital supply chain technology for competitive advantage

Few CMOs have unlocked the potential of digital technologies; however, those that have reported a significant increase in productivity and client satisfaction.

“The pharma industry is consistently managing complex changing regulations that impact how CMOs manage their products,” explained Suzanne Ivory, Perigord Data Chief Operating Officer (COO).

“Pharma companies frequently operate on many fronts simultaneously, investing in product development, launching into new markets while trying to manage existing projects. Outsourcing offers a means for companies to insulate themselves from these pressures, shifting the responsibility of project success to the CMO. Managing risk is a key driver in the decision of what and to whom projects are outsourced, GLAMS CMO is a risk mitigation platform that allows big pharma maintain full project oversight on what and how their CMOs are managing the packaging and artwork process.”

GLAMS CMO is a fully secure system which allows for the end to end management of the artwork function, and provides a secure repository of all artwork, manages approvals and facilitates a full audit trail of all interactions and signoffs carried out during the artwork process.

Click here to register for our webinar

About Perigord:

Perigord Data is a Global Life Science focused business and the software division of Perigord.

Employing over 350 subject matter experts across its offices in Europe, the US and Asia, Perigord offers a suite of products including Packaging and Labelling artwork services, Creative and Design Solutions, Knowledge Processing Outsourcing, Supply Chain Consultancy and dedicated Software solutions.

With a passion for innovation and over 30yrs experience servicing the global packaging, labelling and marketing supply chain needs of the Life Science industry, Perigord is proud of its role in ensuring all Life Science packaging and marketing materials are created and delivered in compliance to all local and global market regulations.

Perigord provides supply chain solutions to 15 of the world’s top-20 Life Science companies.

Perigord “Empowering the Digital Supply Chain”

Contact us:
mediarelations@perigord-as.com
twitter: @Perigord_AS
Global Headquarters
Perigord Data Ltd,
Life Science Artwork Solutions
Unit 1, Lyncon Court, IDA Business & Technology Park
Snugborough Road, Blanchardstown
Dublin D15 N283
Ireland +353 1 440 3222

Risk in the Life Science supply chain is inevitable. 

It’s not a matter of if your company is going to manage risk, it’s a matter of how, and more importantly, how well.

In terms of potential risk, the packaging and labelling process is one of the most vulnerable elements of a product’s life cycle. The risks, ranging from incorrect or incomplete product information to translation errors or incorrect specifications and versions being used, all share the human element as the consistent point of failure.

Any of these issues can lead to a regulatory breach, a delay in getting a product to market, a recall, or even a critical consequence for the patient. And while the packaging process is designed to identify, eliminate, and correct any potential issues, it is itself subject to the law of unintended consequences, meaning the process itself could cause new defects to be created.

Facing into this scenario, emerging & small pharma businesses looking either to enter the space or continue to flourish in it, need to seize upon any advantage they can get.

“The challenges small pharma companies are facing are clear but daunting,” explained Perigord’s Chief Operations Officer, Suzanne Ivory.

“Foremost amongst them are deciding what processes to put in place; how to meet evolving validation and compliance requirements; and ensuring pharma packaging regulations are adhered to, and will continue to be met in the future. Managing these factors effectively and improving efficiencies can give companies a competitive edge.”

GLAMS Q can provide that edge.

Introducing the latest addition to the Perigord stable of artwork management solutions

GLAMS Q was specifically built for smaller pharma businesses offering them a solution, validated from day 1, it offers a streamlined solution for getting a company’s packaging process up-and-running with minimum effort and maximum effect.

A proven, cost-effective solution, GLAMS Q is designed specifically to allow users take control of their pharma labelling and artwork management process. The platform provides all the tools required to ensure full compliance with industry regulations and a quick and easy path to adapting the system to constantly shifting regulatory requirements.

GLAMS Q is a secure, fully validated system and the only labelling and artwork management system on the market developed specifically for the Life Sciences industry.

Helping to significantly reduce rework requirements – and therefore reducing overall time-to-market.

GLAMS Q provides users a complete suite of text and graphics comparison tools to complete all their proofreading and quality checks in one place. The tools also allow users to directly annotate artworks and collaborate with others to identify and eliminate errors completely.

Further efficiencies come from quick task assignment, best practice workflows and clear approval stages. GLAMS Q reduces the time and effort spent on tracking sign-off sheets, trawling through emails, searching for master files and interpreting clunky Excel-based trackers.

GLAMS Q offers a lightweight installation process with heavyweight functionality. There are no lengthy install procedures or complex system implementation requirements. The platform comes pre-configured with an two industry best practice workflows allowing users to hit the ground running.

There is also a clearly defined path to progress any instance of GLAMS Q to GLAMS Enterprise, Perigord’s flagship LAMS, so as organisations grow in size and complexity, the platform provides a stable base to keep packaging processes efficient and compliant.

To Celebrate the launch of GLAMS Q, Perigord will be hosting an informative webinar on Thursday 6th of December for Small Businesses entitled “How to Optimise Your Labelling & Artwork Process with Ease”

About Perigord

Perigord is an Irish company and has been providing artwork solutions for over 40 years, specialising in the Life Science industry for more than a decade. Headquartered in Dublin, Ireland, it has sales, software development and artwork production hubs across the globe, employing over 330 people full time between its Dublin office, three sites in in the US; and Asia.

Contact Information:

Suzanne Ivory
Chief Operations Officer
Perigord Data Solutions Ltd,
Unit 1, Lyncon Court, IDA Business & Technology Park
Snugborough Road, Blanchardstown
Dublin
D15 N283
Ireland
+353 1 440 3222

We are proud to be selected as finalists for the 2018 “Supplier of the Year” award at the Irish Pharma Awards on the 23rd October at the Clayton Hotel Burlington Road, Dublin. Perigord has been supporting Irish Pharma companies and Global Pharma companies based in Ireland for over 10 years.

This award recognises the outstanding support we provide to all our clients in Ireland and globally, but above all acknowledges the contribution and hard work of all our global staff who thrive on delivering the highest levels of compliance and client service to our clients.

Perigord has been and continues to be a leading supplier of consultancy and labelling artwork solutions to the pharma industry worldwide. We work with our clients on everything from setting up their artwork processes, supplying expert resources to product launches and maintaining packaging compliance requirements.

Perigord plays a key role in ensuring all pharma product packaging complies with country regulations locally and globally and provides artwork solutions to 15 of the world’s leading top 20 pharmaceutical companies.

We pride ourselves on ensuring our client’s labelling artwork management needs are always met on time, every time and through regular monitoring, we ensure the highest level of quality and compliance are constantly maintained.

With more than 10 years of experience in the Life Science Industry, Perigord reduces the risk of product recalls caused by packaging and labelling non-compliance – ensuring Ireland’s key export sector keeps growing for years to come.

Perigord, providers of industry leading artwork and labeling solutions to Life Science companies are excited to announce their new cost-effective, high quality and compliant 3D Artwork Services. Our new 3D offering has garnered great feedback from our pharma clients. Delivered with the same commitment to quality and dedication to meeting our clients targets, Perigord's 3D services can become the centerpiece of your next marketing campaign. 

Perigord's 3D Services offers extends beyond standard still images to fully animated video, complete device renders and even 360° rotating PDFs.  Get full previews of all Perigord's 3D Services on this page. 

Investment will be used to facilitate rapid international growth of their software product, GLAMS (Global Artwork Management System)

Dublin, Ireland, August 10th, 2017. Perigord, a Dublin based company specialised in artwork solutions for the pharma and life science industries, recorded 100% growth last year in its software division. In 2017, the company is on track to exceed this figure and the BDO Development Capital Fund supports this growth with an investment of €3 million. This will bring the total investment to €5.4 million, since the first input made by the Fund in February 2016.

With two complementary divisions and a global office network in Europe, USA and Asia, Perigord will use the investment to facilitate international growth of their software product, GLAMS (Global Artwork Management System), as well as continue their supply of precision global artwork services to pharmaceutical and life science companies worldwide.

Alan Leamy, CEO of Perigord, has ambitious plans for scaling the business and the recent investment will help the company to realise these goals. Perigord’s latest software is setting the global standard for management of artwork in the heavily regulated pharma and life science sectors.

Perigord currently have over 250 staff worldwide with centres in Europe, Asia and the USA, and their customer base has expanded to include nine of the world's top ten pharmaceutical companies.

Alan Leamy commented on the recent investment: “BDO Development Capital Fund’s investment has presented the company with a great opportunity to grow on a global scale. It will allow Perigord to service the rapidly expanding life sciences sector as it goes through significant changes and growth in the coming 5-year period. With this investment and the recent upsurge in demand for the product, Perigord are poised to unlock this growth and position itself as the dominant player in this heavily regulated sector.”

Sinead Heaney, Investment Director at the BDO Development Capital Fund, is delighted to be supporting Perigord at such a pivotal time: “The BDO Development Capital Fund supports businesses which demonstrate the ambition, capability and strategy to deliver global expansion and achieve market leading positions. This follow-on investment demonstrates how much potential we see for Perigord moving forward. They have the ambition, capability and strategy to become a leading player in this sector”.

On Saturday, April 1st, Perigord employees participated in the 'Bray 10KM Cliff Run'. This outdoor activity started in Greystones, and took us across the breath-taking cliff route to Bray.

Some weeks before the event, we had an informative and practical session offered by personal trainer Aaron Horan, who shared his experience and best practices to help us in our preparation.

The run was a huge success, and not only a wonderful opportunity to strengthen our team spirit and bring back more positive energy to our office, but a chance to raise funds that will be donated to a preferred charity at the end of this year. Perigord is known for organising different activities throughout the year to raise fund for charities.

Big thank you to all who took part in making 'Bray 10KM Cliff Run' another successful day out for Perigord! We are very proud of your achievement!

Perigord sponsored and attended the '5th Annual Pharma Labeling Compliance Conference' on March 29-30, 2017 in Boston, USA.

This important event brought together pharma industry thought-leaders and specialists from companies across the globe to explore the emerging challenges and regulatory trends through presentations, discussions and networking. This year, the key topics of the conference were:

• Developing an agile and actionable labelling strategy to prepare for the regulatory changes and the evolving industry requirements.
• Creating a robust end-to-end tracking system to centralise labelling.
• Comparing and contrasting pharma and medical device labelling to maximise efficiency across industries.
• Incorporating human factor data in the label to improve product literacy.

We are very proud of our Global Quality Director; Suzanne Ivory, who presented and shared her expert knowledge on solutions to optimise end-to-end artwork processes. As the challenge to provide adequate artwork becomes more complex and the need for artwork management systems becomes more critical, we believe that sharing our expertise will help pharmaceutical labelling leaders to find innovative solutions to these challenges.

This has been another successful year for the 'Annual Pharma Labeling Compliance Conference' and we are already looking forward to next year!

Perigord Acquires Pharma International

• Positions for rapid growth in North and South America
• Expands services to better serve its labeling artwork customers in the life science sector 
• CEO of Pharma International will join Perigord in executive capacity as part of our Global Leadership Team 
• Combined number of pharma/medical device customers grows to 30, ranging from emerging and midsized companies to the world’s largest  

Dublin, Ireland, and Syracuse, New York, December 1st, 2016 - Perigord today announced it has acquired Pharma International, Inc. (“PII”), for an undisclosed amount and effective immediately.  All employees of PII will join Perigord, with the combination expected to deliver the most robust menu of labeling and labeling-related services available in the industry.  Currently serving customers ranging from emerging pharma companies launching their first product to the largest pharma companies in the world, the goal of the expanded business is to continue to grow with the customers and to increase the number of customers served.

Perigord has expanded rapidly over the past several years, with operations in Europe, Asia, North America, and near-term plans to broaden into South America. The company is a global leader in delivery of best-in-class labeling artwork to life science companies, combined with GLAMS, a functionally robust, 21-CFR compliant, cloud-based, artwork management system. 

PII specializes in design, translation, medical illustration, and content development for life science company labeling and web initiatives. The company develops labeling-related materials including Instructions for Use, Starter Kits, Marketing PIs, and patient and provider education tools. Also, the company creates customer-specific style guidelines and right-first-time audit documents that improve consistency across company and product branding. Many PII customers are now in their second decade of relationship with the company and the company has won many of the industry’s major design awards.

The combined Perigord/PII team will collaborate to bring a new standard of accuracy, speed, consistency, compliance, and control to the development and management of a labeling library for its life science customers. “This is a coming together of two companies who share the same commitment to quality, and dedication to the life science sector,” said Perigord CEO Alan Leamy. “We look forward to bringing our global footprint, platform and technology to PII customers and we look forward to the expanded menu of services this merger brings to Perigord customers.” 

Perigord dramatically expands our capacity and presents an opportunity for PII to globalize our services overnight,” said PII CEO Gary Schueler. “Our life science customer base is largely North America. We look forward to offering expanded services to our US customers and partnering with Perigord to offer our services to their customers across the globe.” 

Perigord contact:  Mark Ennis, Global Business Development Director 
mark.ennis@perigord-as.com 
+ 353 1 4403 222 

Pharma International contact:  Orna Bresler, VP of Account Services  
obresler@pharma-ii.com 
+1 315.472.3998 x 236 

Perigord partners with GlobalVision to integrate artwork management solutions.

Dublin, Ireland, September 7, 2016.

Perigord, innovators in Life Science Artwork Management Services and Solutions, and GlobalVision, leaders in the design and delivery of Innovative Proofreading Technologies, today announced their alliance for the integration of their artwork management systems in order to better service the Life Science Industries.

Perigord, recognising the value of working with GlobalVision, who have over 25 years’ experience in proofreading, has entered this strategic collaboration to enable seamless integration of GlobalVision’s Proofware software into their GLAMS (Global Artwork Management System) solution, resulting in streamlined exchanges and decreased time to market in the artwork processes.

Perigord’s GLAMS is a Configurable Off the Shelf (COTS) solution for Artwork Management that meets the current and future needs of Life Science customers.  GlobalVision’s Proofware brings an advanced suite of application tools focused on delivering accuracy and traceability for Quality Control, reducing artwork rework cycles and cost. Through the integration of these software management systems, the user will benefit from quicker file comparisons during proofreading, improved quality control and earlier error detection.  In addition, both systems facilitate 21 CFR Part 11 compliance to electronic records and electronic signature rules.

"We are excited to team with GlobalVision as they, like us, are specialists in the Life Science Industries and understand the GMP environment”, says Alan Leamy, CEO Perigord.  “As one of our new partners, GlobalVision represent our belief that the future of artwork management through the lifecycle process requires integrated automated technologies as a necessity of providing accurate artwork to market, on time and right first time.”

Jonathan Hou, Director of Technology at GlobalVision, also comments: “At GlobalVision, we are looking forward to the synergy this strategic partnership can bring to current and future clients, and we recognize that Perigord’s business mission fits very well with that of our Life Science focus.”

About Perigord

Perigord are specialists in the provision of artwork and labelling outsource services and management solutions to the Life Science Industries globally. Perigord’s unique combination of offerings and technical expertise, coupled with our ability to continually deliver Right First Time artwork, offers the Life Science Industries the perfect solution for outsourced artwork production.

Perigord’s flagship software product GLAMS (Global Artwork Management Software) is a web-based Life Science Artwork Management Solution, developed and designed to control and manage artwork through the artwork lifecycle. 

Contact

Mark Ennis

Contact Us

About GlobalVision

GlobalVision is the world leader in the design of innovative proofreading technologies. With over 25 years of experience, we've helped customers increase proofreading accuracy, efficiency, and speed. Our solutions have been integrated into the packaging workflows of leading consumer packaged goods companies, printing firms and over 70% of the top pharmaceutical companies worldwide.

Contact

Michael Malz

Contact GlobalVision